BioSpace News Archive

Scientists with City of Hope®, one of the largest cancer research and treatment organizations in the United States, and the Translational Genomics Research Institute, part of City of Hope, may have discovered one of the causes for a type of leukemia to develop into a more aggressive form, according to recent research published in Nature Communications.

Adolore BioTherapeutics (“Adolore” or the “Company”), a company focused on developing breakthrough opioid-free gene therapy treatments for chronic pain, today announced that Roelof Rongen, CEO of Adolore, will participate at the Virtual Investor Ask the CEO Conference on Wednesday, October 25, 2023 at 3:00 PM ET.

MoonLake Immunotherapeutics (“MoonLake”; Nasdaq: MLTX) announced that positive 12-week results from its global Phase 2 MIRA trial evaluating the efficacy and safety of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa (“HS”) were presented today during a late-breaking session at the European Academy of Dermatology and Venereology Congress (“EADV”) held in Berlin, Germany.

Incyte (Nasdaq:INCY) today announced new results of a pooled analysis of long-term extension (LTE) data from the pivotal Phase 3 TRuE-V program assessing Opzelura® (ruxolitinib) cream 1.5% in patients 12 years of age and older with nonsegmental vitiligo who previously experienced limited or no response to treatment at Week 24.

Aviceda Therapeutics, a privately held, late-stage clinical biotech company focused on developing next-generation immunomodulators by harnessing the power of glycobiology to alleviate chronic non-resolving inflammation, announced today the recent presentation of positive data about AVD-104, its lead ophthalmic clinical asset, at the EURETINA congress held in Amsterdam, Netherlands, from October 4–7, 2023.

Care Access announced today the completion of a for-cause Food and Drug Administration (“FDA”) Good Clinical Practices (“GCP”) inspection related to Care Access’s activities on the Pfizer VALOR trial.

Quanta Therapeutics, a privately-held biopharmaceutical company pioneering targeted therapies to treat RAS-driven cancers, announced data from a late-breaking presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics being held October 11-15, 2023, in Boston, Massachusetts.

Biocare Medical, a trusted provider of immunohistochemistry (IHC) instrumentation, antibodies and molecular probe for tumor diagnostics, is proud to announce a strategic partnership as the preferred vendor for histology and IHC at EmeritusDX, a world-class CAP accredited and CLIA certified laboratory.

Insight Therapeutics, LLC, a contract research organization focused on improving the care of older adults, announced a major expansion in its research capabilities.

Inari Medical, Inc. announced that it will release its third quarter 2023 financial results on Wednesday, November 1, 2023.